Skip to main content

Table 3 Outcomes and adverse events

From: Primary success of electrical cardioversion for new-onset atrial fibrillation and its association with clinical course in non-cardiac critically ill patients: sub-analysis of a multicenter observational study

Variable Primary success group (n = 35) Unsuccessful group (n = 30) P value
AF at ICU discharge/survivors 0/23 (0) 3/25 (12) 0.24
ICU mortality 12 (34) 5 (17) 0.10
Length of ICU stay among survivors (day) a 9 (6-13) 15 (6-24) 0.22
Hospital mortality 16 (46) 10 (33) 0.31
Length of hospital stay among survivors (day) b 47 (28-64) 50 (36-103) 0.35
Anticoagulation c 15 (43) 13 (43) 0.97
Bleeding event 3 (9) 1 (3) 0.62
Ischemic stroke 2 (6) 1 (3) 1.00
  1. Values are given as median (interquartile range) or number (%)
  2. aTwenty-three patients in the primary success group and 25 patients in the unsuccessful group were survived to discharge from the ICU
  3. bNineteen patients in the primary success group and 20 patients in the unsuccessful group were survived to discharge from hospital
  4. cNumber of patients that received anticoagulation therapy within 7 days after initial AF onset or before ICU discharge if that occurred within 7 days
  5. ICU Intensive care unit